Back to Crohns Disease And Colitis
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT02508012

NCT02508012
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You have been diagnosed with Crohn's disease or ulcerative colitis
  • You are currently being treated with an anti-TNF medication (a type of drug that reduces inflammation by blocking a protein called TNF)

Who may not be able to join:

  • You have a medical reason why you cannot take anti-TNF medications (confirm with trial site)
  • You have previously been treated with anti-TNF medications before (prior to this trial)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
University Hospital, Montpellier
Registry
clinicaltrials_gov
Start date
24 September 2015
Est. completion
1 January 2020

Where this trial is recruiting

🇫🇷 France

Primary endpoints

cost-utility analysis of the immunomonitoring strategy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov